Sonnet BioTherapeutics I... (SONN)
NASDAQ: SONN
· Real-Time Price · USD
3.38
-0.38 (-10.11%)
At close: Aug 15, 2025, 11:19 AM
Sonnet BioTherapeutics Revenue
Sonnet BioTherapeutics reported an annual revenue of $18.63K, reflecting a -87.4% growth. For the quarter ending June 30, 2025, Sonnet BioTherapeutics generated $0 in revenue.
Revenue (ttm)
18.63K
Revenue Growth
-87.4%
Price / Sales Ratio
235.35
Revenue / Employee
1.43K
Employees
13
Market Cap
21.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|